Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Targher

Showing results (71-80 of 638) with videos related to

Pageof 64
Sort By:
Diabetes, Obesity & Metabolism|July 29, 2021
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complicationsChristopher D Byrne, Giovanni Targher
The Lancet. Diabetes & Endocrinology|June 6, 2022
How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?Christopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2015
Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?Giovanni Targher, Christopher D Byrne
Gastroenterology|November 26, 2015
Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver DiseaseChristopher D Byrne, Giovanni Targher
Current Obesity Reports|March 8, 2024
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Giovanni Targher
Gut|September 12, 2021
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is neededChristopher D Byrne, Giovanni Targher
Nature Reviews. Nephrology|February 21, 2017
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney diseaseGiovanni Targher, Christopher D Byrne
European Heart Journal|December 5, 2019
Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular riskGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|October 22, 2015
Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogramGiovanni Targher, Christopher D Byrne
Journal of Hepatology|September 6, 2017
A fatty liver leads to decreased kidney function?Giovanni Targher, Sven M Francque
Pageof 64

Showing results (71-80 of 638) with videos related to

Sort By:
Pageof 64
Diabetes, Obesity & Metabolism|July 29, 2021
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complicationsChristopher D Byrne, Giovanni Targher
The Lancet. Diabetes & Endocrinology|June 6, 2022
How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?Christopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2015
Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?Giovanni Targher, Christopher D Byrne
Gastroenterology|November 26, 2015
Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver DiseaseChristopher D Byrne, Giovanni Targher
Current Obesity Reports|March 8, 2024
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Giovanni Targher
Gut|September 12, 2021
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is neededChristopher D Byrne, Giovanni Targher
Nature Reviews. Nephrology|February 21, 2017
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney diseaseGiovanni Targher, Christopher D Byrne
European Heart Journal|December 5, 2019
Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular riskGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|October 22, 2015
Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogramGiovanni Targher, Christopher D Byrne
Journal of Hepatology|September 6, 2017
A fatty liver leads to decreased kidney function?Giovanni Targher, Sven M Francque
Pageof 64